Davidson Matt bought AZR
November 2, 2026 · Form 4 insider transaction
Davidson Matt bought 524,954 shares of Adial Pharmaceuticals Inc, a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
524,954
Price
N/A
Total value
N/A
InsiderDavidson Matt
Role—
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateNovember 2, 2026
Filing dateNovember 4, 2026
Shares owned after819,018
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Subject to certain beneficial ownership and other limits set forth in the Certificate of Designation of the Series A Preferred Stock, each share of Series A Preferred Stock converted into 1,000 shares of the Issuer's common stock and has no expiration date.